DR KAPIL KUMAR –TOP CANCER SURGEON IN INDIA

  • Dr. Kapil Kumar is one of the best oncologist surgeons in Delhi,  presently working as a Director & HOD- Surgical Oncology at Fortis Hospital.   
  • Dr. Kapil Kumar has well experience in Breast cancer and oncoplastic surgery, Upper G.I Oncology Surgery, Pancreatic Biliary Surgery, Thoracic surgery including Esophagus cancer, Lung cancers & Mediastinal tumors,  Breast Cancer, Gastrointestinal Cancer, Gyne Oncology, Head & Neck Cancer, Hepatobiliary Cancer,  and Lung cancer.

Experience

  • Dr. Kapil Kumar is a Senior Consultant - at Rajiv Gandhi Cancer Inst. & Research Centre, Rohini, Delhi
  • Consultant - Oswal Cancer Hospital, Ludhiana, Punjab
  • Senior Consultant - Batra Hospital and Medical Research Centre, New Delhi
  • Honorary Senior Consultant - Dharamshila Cancer Hospital, New Delhi

Fellowship / Membership

  •  Dr. Kapil Kumar Life Member, Indian Society of Oncology (I.S.O.)
  • International Society of Diseases of Esophagus (I.S.D.E.)
  • Life Member, Delhi Medical Association (D.M.A.)

Awards and achievements  

  • Dhanvantari award from Cholay1 Foundation for Onco- Surgery work

Publication:

  • Peritoneal Echinococcus Multi Loculari's Infection: CT appearance J, Comput, Assist, Tomogr, Vol.14, No.-3, 1990.
  • Surgical Oncology in the third millennium: Why Sacrifice more when less will do - Journal of Safdarjang Hospital, Volume VII Jan. 2000, 31-34.
  • Changing concepts in Breast Cancer – Chandigarh Medical Journal - September 2002.
  • MRI- guided biopsy- Our preliminary experience. Indian J Radiol Imaging – August 2010.
  • Kras Gene Mutation and RASSF1A, FHIT & MGMT Gene Promoter Hypermethylation Indicators of Tumor Staging and Metastasis in Adenocarcinomatous Sporadic Colorectal Cancer in Indian Population.- April 2013
  • P16(INK4a) promoter methylation and expression in sporadic breast cancer. -Journal of Carcinogenesis-Sep.2012
  • MGMT & RASSF1A Gene promoter hypermethylation in sporadic colorectal cancer in the Indian population. - Journal of Carcinogenesis-Sep.2012.
share